Pro 2012-005 (Announcement of Resolutions of the 4th Session of the 8th Board of Directors of Jianfeng Group)
Release time:
2020-08-05
证券代码:600668 证券简称:尖峰集团 编号:临2012-005
浙江尖峰集团股份有限公司八届四次董事会决议暨召开2011年年度股东大会的公告
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。
二〇一二年三月二十六日,浙江尖峰集团股份有限公司以传真、电子邮件及专人送达的方式发出了召开第八届董事会第四次会议的通知。二〇一二年四月六日,会议如期在浙江金华尖峰大厦会议室召开。会议由蒋晓萌董事长主持,全体九名董事亲自参加了会议;部分监事和高级管理人员列席了会议,符合《公司法》和《公司章程》的有关规定,所做决议合法有效。会议通过了如下决议:
一、通过了2011年度总经理业务报告
表决结果:同意9票、反对0票、弃权0票。
二、通过了2011年年度报告及其摘要
表决结果:同意9票、反对0票、弃权0票。
该报告将提交股东大会审议。
三、通过了2011年度财务决算报告
表决结果:同意9票、反对0票、弃权0票。
该报告将提交股东大会审议。
四、通过了2011年度利润分配预案
经天健会计师事务所审计,2011年度公司归属于母公司股东的净利润268803858.08元,按母公司的本期净利润109774881.48元为基数,提取10%法定公积金10977488.15元。本年度可供分配的利润为257826369.93元,加年初未分配利润259763197.82元,本年度可供分配利润为 517589567.75 元。
公司2011年度拟进行现金分配,以2011年末股本344083828股为基数,每10股派发现金红利1.2元(含税)。2011年度不进行公积金转增股本。
表决结果:同意9票、反对0票、弃权0票。
该报告将提交股东大会审议。
五、通过了对外担保的议案
董事会一致通过了该议案,同意以下各项对外担保事宜。
(一)对控股子公司的担保
1、对于控股子公司向金融机构借款提供担保,设定如下额度:
|
被担保单位 |
本次设定担保额度(万元) |
|
大冶尖峰水泥有限公司 |
30000 |
|
浙江尖峰药业有限公司 |
20000 |
|
金华市医药公司 |
2000 |
|
浙江尖峰国际贸易有限公司 |
1000 |
|
云南尖峰水泥有限公司 |
20000 |
|
总 计 |
73000 |
2、随着浙江尖峰国际贸易有限新增仓库投入运行,仓储业务量增加,成功引进了中国石化等大型企业的仓储业务,还成为大连商品交易所的PVC、PE期货交割仓库,此等业务需第三方提供担保。公司拟同意出具担保函,为浙江尖峰国际贸易有限公司的客户存放的货物提供相应的担保(详见公告临2012-007)。
(二)互保
同意与浙江凯恩特种材料股份有限公司实行额度5000万元的互相担保。在其履行相关程序后,公司将与其签订互保协议,期限为一年(详见公告临2012-008)。
并提请股东大会授权在上述额度内的担保由董事长根据实际情况分次执行。
表决结果:同意9票、反对0票、弃权0票。
本预案需报股东大会审议。
六、通过了投资报告
会议审议通过了该报告,批准了报告中提出的投资、技改和新产品开发等项目。
1、大冶尖峰水泥有限公司机修车间技改项目,计划投资220万元。
2、浙江尖峰药业有限公司滴眼液生产线技改项目,计划投资680万元。
3、浙江尖峰药业有限公司单独出资设立保健品销售公司,注册资本1000万元。
4、对浙江尖峰国际贸易有限公司增资,计划增资1000万元。
5、尖峰药业新产品开发。尖峰药业拟投入3900万元(按阶段成果分期支付)与中国药科大学及其医药化工研究所等相关方合作,进行抗肿瘤一类新药(DPT)的临床前研究。
6、出让北京勤益科技投资管理有限公司股权。
北京勤益科技投资管理有限公司注册资本4000万元,其中本公司出资475万元(占11.875%),公司拟以546.25万元出让该股权。
表决结果:同意9票、反对0票、弃权0票。
七、关于聘请公司2012年度审计机构的议案
同意聘请天健会计师事务所有限公司为公司2012年度财务报告及其他审计业务的审计机构。审计费用参照有关规定,以业务量为衡量标准,请股东大会授权董事会与该所谈判为准。审计期间的食、宿等费用由公司承担。
表决结果:同意9票、反对0票、弃权0票。
本预案需报股东大会审议。
八、通过了2011年度董事会报告
表决结果:同意9票、反对0票、弃权0票。
该议案需提交股东大会审议。
九、通过了召开2011年度股东大会方案
(一)会议召开时间:2012年5月8日上午9:00。
(二)会议召开地点:浙江省金华市婺江东路88号尖峰大厦。
(三)会议主要议程:
1、审议2011年度董事会工作报告;
2、审议2011年度监事会工作报告;
3、审议2011年度财务决算报告;
4、审议2011年度利润分配方案;
5、审议聘请2012年度审计机构的方案;
6、审议对外担保的方案;
7、审议2011年年度报告及其摘要。
(四)出席对象
1、凡2012年5月3日(股权登记日)交易结束后在中国证券中央登记结算公司上海分公司登记在册的本公司股东及其授权委托人均可出席。
2、本公司董事、监事及高级管理人员。
(五)会议登记办法
1、法人股股东持单位证明、法人代表委托书和出席人身份证登记;社会公众股股东凭股东帐户卡、本人身份证登记。股东可以信函或传真方式进行预登记。
2、预登记时间:2012年5月7日。
3、登记地点:浙江省金华市婺江东路88号尖峰大厦。
表决结果:同意9票、反对0票、弃权0票。
特此公告
二〇一二年四月六日
浙江尖峰集团股份有限公司董事会
附件 授权委托书样:
兹全权委托 先生(女士)代表本人出席浙江尖峰集团股份有限公司2011年年度股东大会,并依照委托人指示就各议案进行投票,如果委托人没有指示则由受托人自行投票。
委托人签名:
委托人股东帐号: 委托人身份证号码:
委托人持股数:
受托人签名: 受托人身份证号码:
有效期:
委托日期 年 月 日
More information
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-30
Peak Pharmaceutical Becomes National Intellectual Property Demonstration Enterprise
Just one year after it was identified as a national intellectual property advantage enterprise in 2016, "Zhejiang Jianfeng Pharmaceutical Co., Ltd." appeared in the list of national intellectual property demonstration enterprises in 2017 recently announced by the State Intellectual Property Office. As a result, Jianfeng Pharmaceutical has become the first and only national intellectual property demonstration enterprise in Jinhua City. On December 12, the State Intellectual Property Office issued a notice to announce the list of national intellectual property demonstration enterprises and advantageous enterprises in 2017. After the enterprise declaration, the recommendation of the provincial and municipal bureaus, the review of the national bureau, and the public announcement, 182 national intellectual property demonstration enterprises and 816 national intellectual property advantage enterprises have been identified. Including Jianfeng Pharmaceutical, Zhejiang Province has been identified as only 15 national intellectual property demonstration enterprises. With the continuous development of enterprises in recent years, Jianfeng Pharmaceutical has set up a special working organization to cultivate and improve the intellectual property ability from the aspects of strategic management, creation, operation and protection of intellectual property rights. It has successively compiled and implemented 27 procedural documents and 36 forms such as "Intellectual Property Management Manual", "Intellectual Property Reward and Punishment System" and "Trade Secret Management System, and timely according to the policy, the current situation of the enterprise to revise, in order to ensure the compliance and effectiveness of the operation of the system. In 2012 and 2013, Jianfeng Pharmaceutical was successively rated as a patent demonstration enterprise in Jinhua City and Zhejiang Province; in 2013, it won the third prize of Jinhua Patent Implementation Award; in 2016, it passed the certification of intellectual property management system and was identified as a national intellectual property advantage enterprise. Currently, Peak Pharmaceuticals has
2020
07-31
Jianfeng Pharmaceutical Approved to Set up Provincial Research Institute
A few days ago, the relevant departments of Zhejiang Province approved the establishment of the provincial research institute of the peak pharmaceutical company. This is another honor won by Jianfeng Pharmaceutical in the field of independent research and development and scientific and technological innovation after the national postdoctoral research workstation and Zhejiang academician expert workstation. The provincial enterprise research institute is a high-level R & D institution led by the Provincial Department of Science and Technology, jointly recognized by the Provincial Economic and Information Commission and the Provincial Development and Reform Commission. As an important part of the national technological innovation system, the Enterprise Research Institute is the core force of the innovation-driven development of Jianfeng Pharmaceutical, which reflects the ability of Jianfeng Pharmaceutical to set up higher-level and higher-level R & D institutions on its own. the ability to gather and integrate innovation elements, organize scientific and technological innovation, support the sustainable development of enterprises, and lead the technological progress of the industry. As a pharmaceutical enterprise, scientific and technological innovation is the eternal theme of enterprise development, and talent is the key to scientific and technological innovation. Over the years, Jianfeng Pharmaceutical has not only focused on cultivating its own scientific research talents, but also established close cooperative relations with well-known universities and scientific research institutions such as China Pharmaceutical University, Shenyang Pharmaceutical University, Sichuan Antibiotic Industry Research Institute, and also focused on introducing top think tanks. In 2011, Professor Liu Jiajian and his team from Sichuan Institute of Antibiotic Industry were introduced, focusing on the technical research of key intermediates of methoxy cephalosporin. In 2013, Professor Shan Weiguang and his scientific research team from Zhejiang University of Technology were introduced to carry out research on preparation technology. In 2015, Professor Wang Guangji, academician of the Chinese Academy of Engineering, was hired as the chief scientist to organize the research on the anti-drug resistance mechanism of national class I new drugs by intracellular pharmacokinetics. In 2017 with Shanghai antibody
2020
07-31
On November 16, the company held the first extraordinary general meeting of shareholders in 2017, which deliberated and passed the proposal on the expiration of the term of the board of directors and the proposal on the expiration of the term of the board of supervisors, and elected a new board of directors and the board of supervisors. The meeting used a combination of on-site registered voting and online voting to vote on director candidates one by one, and elected Jiang Xiaomeng, Du Zihong, Yu Jianhong, Huang Sujian, Liu Bo, Zhang Guoping, Huang Conyun, Sun Hongbin, and Shi Ximin as the company's tenth board of directors. Directors, of which Huang Conyun, Sun Hongbin, and Shi Ximin are independent directors. The meeting used a combination of on-site registered voting and online voting to vote on supervisor candidates one by one, and elected Chen Tianci, Lu Ruimei, and Shi Fu as supervisors of the company's ninth board of supervisors. Prior to this, the company's trade union held an enlarged meeting of the trade union committee to elect Qin Xuping and Jin Huazhong as employee representative supervisors of the ninth board of supervisors. On the same day, the company's tenth board of directors held its first meeting and elected Jiang Xiaomeng as the chairman of the tenth board of directors. Jiang Xiaomeng, Du Zihong, Huang Sujian, Sun Hongbin and Shi Ximin were elected as members of the Strategy Committee of the 10th Board of Directors, and Jiang Xiaomeng was the chairman of the Strategy Committee. Shi Ximin, Huang Conyun and Jiang Xiaomeng were elected as members of the audit committee of the 10th board of directors, and Shi Ximin was the chairman. Sun Hongbin, Huang Conyun and Jiang Xiaomeng were elected as members of the nomination committee of the 10th board of directors, and Sun Hongbin was the chairman. Huang Cong Yun, Shi Ximin and Du Zihong were elected as members of the remuneration and assessment committee of the 10th board of directors, and Huang Cong Yun was the chairman. The board of directors appointed Yu Jianhong as the general manager of the company and appointed Huang Jinlong.
2020
07-31
Peak natural products pollution control results by the industry attention
As a leader in China's plant extracts industry, Tianjin Jianfeng Natural Products Company has achieved fruitful results in technological innovation. On October 26 and 27, at the 2017 Forum on improving the international competitiveness of China's plant extract industry held in Handan City, Hebei Province, Liu Dan, general manager of the company, delivered a speech entitled "prevention and control of water pollution in the field of plant extraction", introducing the successful experience of sewage treatment in the past five years, which was widely concerned by the participants. In recent years, environmental protection and ecology have become hot words for the development of enterprises and society. Due to the particularity of the plant extraction industry, pollution control in this industry has different characteristics and requirements from ordinary production enterprises. For example, sewage presents higher chroma, extremely low PH value, more suspended solids, high salinity, high concentration of COD, and different sewage water quality of different products. As the earliest enterprise producing opc grape seed extract in China, Natural Products Company has always attached great importance to the pollution control of plant extraction. For example, in the sewage treatment upgrading project implemented in 2016, ozone oxidation and biochemical methods were adopted to remove the remaining organic pollutants, increasing the sewage treatment capacity from 200 cubic meters per day to 500 cubic meters. The latest anaerobic sewage treatment technology is adopted, the COD emission value of the outlet is reduced to 60 mg per liter, which is far lower than the national first-class emission standard of 100 mg per liter. The new system adopts advanced oxidation reaction tower, ozonation method, field energy reactor and sludge adsorption reflux technology, which can quickly and efficiently treat organic pollutants with strong chemical stability without adding any chemicals.
2020
07-31